Loading clinical trials...
Loading clinical trials...
The aim of this study is to determine the effect kiensio taping in relieving pelvic girdle pain during pregnancy in terms of decrease pain and improving function and quality of life.
Severity of pelvic girdle pain can be different, as a result of the progress of the disorders and subjective feeling of pain. According to Kanakaris an average severity of pain in pelvic girdle pain is 50-60 mm scale visual analogue scale. Results may vary according to different factors such as; pregnancy stage, age of the pregnant women, different body mass index. Beyond the discomfort and pain, pelvic girdle pain can also limit the performance of the activities of daily living such as; bending, lifting, sitting, sleeping, housework, long walking, and standing and thus adversely affect the quality of life of pregnant women. Unfortunately, the options for pain therapy in pregnant women are significantly limited due to the possible danger to both mother and fetus. Most of the standard drugs used affect the fetus and are not recommended, especially for long-term treatment. There is very little clinical experience and only limited documentation for effectiveness of Kinesio taping on pelvic girdle pain during pregnancy. Because the existing treatments for pregnancy-related pelvic girdle pain are not adequately known and are not found to be reliable by patients and clinicians. Kinesio taping may be a potential treatment if it is an effective and tolerable method. Therefore, the aim of the present study was to determine the influence of Kinesio taping pelvic girdle pain in pregnant women
Age
18 - 36 years
Sex
ALL
Healthy Volunteers
No
out-patient clinic, faculty of physical therapy, Cairo university
Cairo, Egypt
Start Date
June 1, 2024
Primary Completion Date
December 1, 2024
Completion Date
June 1, 2025
Last Updated
December 18, 2025
72
ACTUAL participants
Kinesio tape
OTHER
Core stability exercises
OTHER
Lead Sponsor
Cairo University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions